Gene Therapy Platforms May Require Less Preclinical Data, Gottlieb Says

Executive Summary US FDA's preclinical policies should be 'more closely matched to the complexion of modern technologies,' commissioner explains.

Executive Summary

US FDA's preclinical policies should be 'more closely matched to the complexion of modern technologies,' commissioner explains.

FDA entrance sign 2016
Source: pink.pharmamedtechbi.com